Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor.

Small biotechs are encouraged to develop robust processes early to avoid wasted time and increased costs on repeating scale-up.

An enzyme in the blue blood has been key to testing vaccines since the 1980s, raising concerns for the crabs’ population. But ...

GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial ...

Gathering and reworking a decade’s worth of blistering live jams, this compilation of four dynamic new EPs captures the recombinant spirit of the jazz drummer, bandleader, and beatmaker.

Dear Savvy Senior, With a longtime vaccine critic leading the nation’s health departments, can you give me updated ...

Immunologist Zachary Rubin explains how the World Health Organization decides which strains of influenza end up in annual flu ...

Two doses of the recombinant zoster vaccine are effective in older adults, including immunocompromised adults.

CSL ( ASX: CSL) cut its fiscal 2026 guidance for revenue and net profit after tax before amortization growth to 3% and 6% at ...